<DOC>
	<DOCNO>NCT00132626</DOCNO>
	<brief_summary>This study assess dopamine transporter density use single photon emission compute tomography ( SPECT ) brain image investigational radiopharmaceutical , [ 123I ] ß-CIT , research participant Parkinson 's disease .</brief_summary>
	<brief_title>Study Brain Imaging With Nuclear Technology Individuals With Parkinsonian Syndrome</brief_title>
	<detailed_description>The brain imaging conduct Institute Neurodegenerative Disorders New Haven , Connecticut . The imaging procedure occur two day period . After screen visit , include review potential subject 's neurological history thorough neurologic exam , subject inject [ 123I ] ß CIT , investigational radioactive material localize brain . Twenty-four hour later study participant return Institute Neurodegenerative Disorders investigational scanning procedure use obtain SPECT ( single photon emission compute tomography ) image brain .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>At least 21 year age Normal screen laboratory study At least two follow : rest tremor , cogwheel rigidity , bradykinesia , postural reflex impairment Pregnancy Significant medical disease include abnormality find screen</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2007</verification_date>
	<keyword>parkinson</keyword>
	<keyword>diagnosis</keyword>
</DOC>